Trials and Tribulations of Antimicrobial Drug Development: Assessing the Economic and Political Landscape
Dr. Kenneth I Kaitin, PhD, presented for the Levy CIMAR Monthly Science Lunch on December 17, 2020. His talk was titled: “Trials and Tribulations of Antimicrobial Drug Development: Assessing the Economic and Political Landscape.”
December 18, 2020
We were privileged yesterday to have the Levy CIMAR’s own Kenneth I. Kaitin, PhD, present at our December 2020 Monthly Science Lunch, a seminar series devoted to engaging with and informing our community about the latest news in antimicrobial research, medicine, drug development, policy, education, and much more.
A Professor and Director of the Tufts Center for the Study of Drug Development (CSDD) at the Tufts University School of Medicine, Dr. Kaitin presented on “Trials and Tribulations of Antimicrobial Drug Development: Assessing the Economic and Political Landscape.” You can watch a recording of his talk below.
As an internationally recognized expert on drug development science and policy, Dr. Kaitin writes and speaks regularly on factors that contribute to the slow pace and high cost of pharmaceutical R&D and efforts to improve the development process. He has provided public testimony before the U.S. Congress on pharmaceutical development, regulation, and policy issues, and he currently serves as an expert consultant to the U.S. Department of Defense on bioterror countermeasures initiatives.
During his 23 years as Tufts CSDD’s Director, the group has tackled complex and timely issues in drug development with confidence and determination, earning global recognition for its scholarly, data-driven analyses, highly cited publications and reports, and critical insights on the challenges of pharmaceutical innovation.